Targeting Type 1 Diabetes via Polyamines: The TADPOL Trial

Targeting Type 1 Diabetes via Polyamines: The TADPOL Trial



The Indiana University School of Medicine is studying a drug for Type 1 diabetes known as difluoromethylornithine (DFMO) that …

source

Leave a Reply

Your email address will not be published.


*